Close Menu

Clostridium difficile

NEW YORK (GenomeWeb News) – Idaho Technology today said that it anticipates commercially launching its blood culture ID and gastrointestinal panels by early 2014.

NEW YORK (GenomeWeb News) – A Leerink Swann survey of diagnostic laboratories in Europe found that molecular-based testing continues to find traction with continued penetration strongest in methicillin-resistant Staphylococcus aureus testing and human papillomavirus testing.

Claremont BioSolutions has been awarded a three-year, $3 million grant from the National Institute of Allergy and Infectious Diseases to continue developing its fully integrated and portable point-of-care assay system for detecting Clostridium difficile infections and co

Great Basin this week named six distributors in Europe and one in New Zealand for its recently commercialized molecular diagnostic test for Clostridium difficile.

Great Basin said this week that it has hired several new employees to support commercialization of the company's first molecular diagnostic assay, a test for Clostridium difficile.

Researchers from clinical lab supply company Streck, the University of Nebraska, Lincoln, and the UN Medical Center have developed a method for extracting and detecting Clostridium difficile DNA from stool samples more rapidly than existing commercial methods and with co

Molecular diagnostics developer PrimeraDx is making headway in its efforts to reach out to pharmaceutical companies to spur adoption of its highly multiplexed, quantitative PCR-based DNA testing platform for companion diagnostic development, according to a company official.

NEW YORK (GenomeWeb News) – Great Basin today announced it has received 510(k) clearance from the US Food and Drug Administration for its first molecular diagnostic test for Clostridium difficile.

Scientists from the Keck Graduate Institute of Applied Life Sciences and KGI spinout Claremont Biosolutions have been developing point-of-care molecular testing platforms and associated assays for Clostridium difficile, multi-drug-resistant tuberculosis, and herpes simpl

Cepheid last week reported a 28 percent spike in first-quarter revenues driven primarily by strong sales in its clinical diagnostics business, including record sequential growth in clinical reagent sales.

Pages

A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.